A Chi­nese com­pa­ny is al­ready mass pro­duc­ing Gilead­'s ex­per­i­men­tal coro­n­avirus drug

In a high­ly un­usu­al step, a Chi­nese com­pa­ny said it has be­gun mass pro­duc­ing an ex­per­i­men­tal Gilead drug that US doc­tors used to treat pa­tients in­fect­ed with the nov­el coro­n­avirus.

Bright­Gene Bio-Med­ical Tech­nol­o­gy Co said in a fil­ing to the Shang­hai stock ex­change that it de­vel­oped tech­nol­o­gy to man­u­fac­ture remde­sivir and be­gan mass pro­duc­ing the ac­tive phar­ma­ceu­ti­cal in­gre­di­ent for the event the drug is ap­proved by Chi­nese au­thor­i­ties while the out­break is on­go­ing. They said they are in the process of mak­ing the full drug.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.